Latest News
Thursday preview: Global manufacturing, Next in the spotlight
Financial markets' focus on Thursday will be on global manufacturing sector conditions in March, including on either side of the Atlantic.
Europe close: Stocks little changed at quarter's end
European shares were little changed in the final session of the quarter, albeit following a three-month run that had seen benchmarks in Germany and France advance by nearly 10%.
Pfizer coronavirus vaccine 100% effective on adolescents
Pfizer and BioNTech announced that the phase 3 Covid-19 vaccine tests on teenagers ages 12 to 15 were 100% safe and effective.
Daimler to accelerate shift to electric vehicles
Daimler AG is pressing ahead with its structural realignment and accelerating its shift towards electric mobility with the aim of turning its full offering CO2-neutral as quickly as possible.
EU expects to receive 107m Covid-19 doses in Q1, 30m from Astrazeneca
The European Union expects to receive 107m doses of the coronavirus vaccine by the end of March, 30m of which will be of that developed by Anglo-Swedish firm AstraZeneca and the University of Oxford.
London close: Stocks finish weaker, Deliveroo slumps on debut
London stocks finished below the waterline on Wednesday, with little in the way of corporate news to drive markets, as investors mulled the latest UK GDP reading.
Director dealings: Synthomer CEO ups stake
Synthomer said on Wednesday that chief executive Callum MacLean had acquired 31,979 ordinary shares in the FTSE 250-listed chemicals group.
Premier African Minerals reports progress at Zulu
Premier African Minerals updated the market on progress and the funding strategy to be applied in the development of both Premier and Zulu Lithium and Tantalum Limited.
Xtract Resources to begin IP survey at Bushranger
Xtract Resources updated the market on exploration work at the Racecourse mineral resource on the Bushranger copper-gold exploration project in the Lachlan Fold Belt of New South Wales, Australia on Wednesday, reporting that a geophysical crew was on its way to the site.
Eden Research partner in Spain gets authorisation for bio-fungicide
Biopesticide and crop protection technology company Eden Research announced on Wednesday that its partner in Spain and Portugal, Sipcam Iberia, has received authorisation for the sale of its bio-fungicide in Spain for use on a range of new crops, for the control of a larger number of fungal pathogens.
Broker tips: Hikma Pharmaceuticals, Vistry Group
Analysts at Jefferies upgraded drugmaker Hikma Pharmaceuticals from 'hold' to 'buy' on Wednesday, stating the group's share price was yet to reflect "a series of upcoming product catalysts".
Berenberg raises target price on Vistry
Analysts at Berenberg raised their target on construction firm Vistry Group from 1,210. 0p to 1,270. 0p on Wednesday, stating there was still more gains to come despite the stock's recent rise.
Chicago PMI rises more than expected in March
Economic activity in the Chicago area improved more than expected in March, according to data released on Wednesday.
Deliveroo slumps on market debut
Deliveroo shares tanked on its market debut on Wednesday, with more than £2bn wiped off the company’s valuation within minutes of the opening bell.
US open: Stocks mixed as investors await Biden's infrastructure plan
Wall Street trading was mixed early on Wednesday as investors awaited more details about Joe Biden's infrastructure spending plan.
Fuller's announces £53m placing ahead of reopening
Fuller, Smith & Turner announced on Wednesday that it was looking to raise around £53m in a share placing to help with the reopening of its pubs in April, as it said full-year revenues are expected to be down 80% on the year.
FTSE 250 movers: Capita rallies, ITV drops in quiet trade
London’s FTSE 250 was flat as a pancake in afternoon trade on Wednesday, at 21,575. 02.
FTSE 100 movers: Hikma rallies on upgrade; BP hit by downgrade
London’s FTSE 100 was down 0. 4% at 6,748. 07 in afternoon trade on Wednesday.
Lloyd's of London posts £900m loss as Covid claims could hit £6.2bn
Lloyd’s of London said it expected 2020 payouts for insurance claims related to the Covid-19 pandemic to hit £6. 2bn as it reported pre-tax net losses of £0. 9bn in an “extremely challenging year”.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.
The value of investments can fall and you may get back less than you invested.